SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form N-CSR - Certified Shareholder Report:
SEC Accession No. 0001104659-20-102265
Filing Date
2020-09-03
Accepted
2020-09-03 16:37:00
Documents
6
Period of Report
2020-06-30
Effectiveness Date
2020-09-03

Document Format Files

Seq Description Document Type Size
1 N-CSR tm2025608d1_ncsr.htm N-CSR 378380
2 CODE OF ETHICS tm2025608d1_99-coe.htm EX-99.CODEETH 51953
3 CERTIFICATIONS tm2025608d1_99-cert.htm EX-99.CERT 20848
4 CERTIFICATIONS tm2025608d1_99-906cert.htm EX-99.906 CERT 6658
5 GRAPHIC tm2025608d1_ncsrimg001.jpg GRAPHIC 6483
6 GRAPHIC tm2025608d1_ncsrimg003.jpg GRAPHIC 24857
  Complete submission text file 0001104659-20-102265.txt   502701

Series and Classes/Contracts Information:

Existing
  Status Name Ticker Symbol
CIK 0001748197      
Series S000066138   INFUSIVE(R) COMPOUNDING GLOBAL EQUITIES ETF
Class/Contract C000213717   INFUSIVE(R) COMPOUNDING GLOBAL EQUITIES ETF
Mailing Address ONE GRAND CENTRAL PLACE 60 EAST 42ND STREET, SUITE 1840 NEW YORK NY 10165
Business Address ONE GRAND CENTRAL PLACE 60 EAST 42ND STREET, SUITE 1840 NEW YORK NY 10165 646-902-6865
Infusive US Trust (Filer) CIK: 0001748197 (see all company filings)

IRS No.: 000000000
Type: N-CSR | Act: 40 | File No.: 811-23426 | Film No.: 201159638